BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27487002)

  • 21. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
    Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
    Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
    Wang YD; Zhai WL; Wang HY; Xia XQ
    Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
    Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
    Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
    Noureddini M; Mobasseri N; Karimian M; Behjati M; Nikzad H
    J Gene Med; 2018 Oct; 20(10-11):e3053. PubMed ID: 30160806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
    Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
    PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D; Jiang H; Gu Q; Zhang D; Li Z
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
    He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
    PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    Xiong Y; Zhang Q; Ye J; Pan S; Ge L
    PLoS One; 2018; 13(11):e0206853. PubMed ID: 30408066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
    Zhang H; Liu H; Jiang G
    PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.
    Forat-Yazdi M; Gholi-Nataj M; Neamatzadeh H; Nourbakhsh P; Shaker-Ardakani H
    Asian Pac J Cancer Prev; 2015; 16(8):3285-91. PubMed ID: 25921133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility.
    Zhu W; Yao J; Li Y; Xu B
    Tumour Biol; 2014 Apr; 35(4):3061-6. PubMed ID: 24258108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene polymorphism of DNA repair gene X-ray repair cross complementing group 1 and xeroderma pigmentosum group D and environment interaction in non-small-cell lung cancer for Chinese nonsmoking female patients.
    Wang L; Wang LL; Shang D; Yin SJ; Sun LL; Wang XY; Ji HB
    Kaohsiung J Med Sci; 2019 Jan; 35(1):39-48. PubMed ID: 30844146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: a meta-analysis of 10846 cases and 11723 controls.
    Bu T; Liu L; Sun Y; Zhao L; Peng Y; Zhou S; Li L; Chen S; Gao Y
    PLoS One; 2014; 9(1):e86086. PubMed ID: 24489692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-ray repair cross-complementing 1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis.
    Wu H; Xu C; Chen G; Wang J
    J Gastroenterol Hepatol; 2014 May; 29(5):926-33. PubMed ID: 24224851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.
    Yi L; Xiao-Feng H; Yun-Tao L; Hao L; Ye S; Song-Tao Q
    PLoS One; 2013; 8(10):e78071. PubMed ID: 24205095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between DNA repair genes (XPD and XRCC1) polymorphisms and susceptibility to age-related cataract (ARC): a meta-analysis.
    Zheng LR; Ma JJ; Zhou DX; An LF; Zhang YQ
    Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1259-66. PubMed ID: 24906341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln), and the risk of age-related cataract: a meta-analysis.
    Liu XC; Liu XF; Hu ZD; Li ZH
    Curr Eye Res; 2015 Jul; 40(7):676-82. PubMed ID: 25285569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk: a meta-analysis.
    Li S; Peng Q; Chen Y; You J; Chen Z; Deng Y; Lao X; Wu H; Qin X; Zeng Z
    PLoS One; 2013; 8(9):e73448. PubMed ID: 24039945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.